placeholder image
H. N. Ginsberg All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes
    JAMA cardiology. 2017
  • Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial
    JAMA internal medicine. 2014
  • Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
    Diabetes care. 2014
  • Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
    Diabetologia. 2012
  • Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants
    Diabetes care. 2012
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes
    New England Journal of Medicine. 2011
  • Effects of combination lipid therapy in type 2 diabetes mellitus
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes
    New England Journal of Medicine. 2010
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods Am J Cardiol
    2007
  • Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
  • Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
  • Contact
    full name
  • H. N. Ginsberg
  • HN Ginsberg
  • Quick Info
     
    Collaboration